Zydus Receives USFDA Approval for Dapagliflozin Tablets with 180-Day Exclusivity
Zydus Receives USFDA Approval for Dapagliflozin Tablets with 180-Day Exclusivity Read Post »
Covers price-sensitive disclosures including accidents, legal issues, defaults, credit rating changes, and major disruptions. These events can significantly impact stock movement.